NEW YORK (GenomeWeb News) - GeneGo today said it has licensed its MetaCore technology to the Reproductive Medicine Associates of New Jersey.
The facility will use the tool to analyze gene-expression data in research and in their clinic. Julie Bryant, vice president of business development at GeneGo, said this is the first time MetaCore will be used by health-care practitioners instead of pharmaceutical companies or academic groups.
Financial details for the multi-year agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.